Letter To Senator Trumbull And Representative Griffitts: Blood Donation Procedural Testing For MRNA Produced Spike Protein

October 20, 2025

by Karen Custer, Chairman / Republican Caucus of Bay County, Florida

BAY COUNTY, FL – Senator Trumbull and Representative Griffitts, I come to you today to humbly ask that you jointly sponsor the first bill of this kind in the nation to address the critical concern for testing of synthetic mRNA spike protein in blood for blood donation purposes. The bill proposal has support from many national and international doctors and health care professionals. The original intent was to test for the presence of synthetic mRNA but that is still only being done through microscopy. The spike testing is a ready test like that of testing for HIV.

Several blood banks offer alternative blood donations, but they rely on the honor system when they ask if a donor has received one of the synthetic mRNA injections. I hope you agree that this is not good enough and that you will work to help us get this bill into the 2026 legislative session.

This is critical to the health of those who made the choice not to get the Covid 19 mRNA injection.

We are asking our Florida legislature to pass the following amendments to FL St 381.0041 regarding certification of the safety of donor blood in our state from contamination with the pathogenic spike protein proven to exist in the COVID-19 injections. In those who are vaccinated with the lipid encapsulated modified, or synthetic, mRNA which produces spike protein (by definition a gene altering agent), the injection has been demonstrated to produce alteration of the recipients' genes which may lead to perpetual production of spike protein, which itself is distributed throughout the body in contrast to usual vaccines.

Blood recipients deserve to know, in accordance with required informed consent, that proper testing has occurred on donor blood to make certain that said recipient does not receive the harmful spike protein or other contaminants which may be present in donor blood.

Credit for this bill should be given to Avery B. Brinkley, Jr. MD, and Mary Helms, Freedom Advocate.

Florida House Bill ___

A bill to be entitled: Blood Donation Procedural Testing for mRNA produced spike protein

An act relating to the donation and transfer of human tissue; amending s. 381.0041, F.S.; requiring blood donations to be tested for modified messenger ribonucleic acid (designated herein as mRNA) produced spike protein without the presence of nucleocapsid antibodies; providing labeling and consent requirements; directing the Department of Health to adopt rules; providing an effective date.

Be It Enacted by the Legislature of the State of Florida:

Amending 381.0041, Florida Statutes, to read:

381.0041 Donation and transfer of human tissue; testing requirements. –

(a) In addition to infectious disease testing otherwise required under this section, any facility engaged in the collection, processing, storage, or distribution of blood or blood components for transfusion shall test all donations for the presence of the nucleocapsid and spike protein antibodies.

(b) Blood and blood components that test positive for the presence of spike protein antibodies only must be:

Clearly labeled as containing detectable levels of spike protein antibodies without detectable nucleocapsid antibodies, which is characteristic of vaccinated blood; and

Segregated from other blood or blood components not containing spike protein antibodies.

The recipient, or the recipient’s legal guardian, provides informed written consent; or

A licensed physician determines that transfusion is medically necessary to prevent imminent serious harm or death, and no alternative blood or blood components are reasonably available.

(d) The Department of Health shall adopt rules to implement this subsection, including, but not limited to:

Establishing uniform standards and protocols for nucleocapsid and spike protein antibody testing of blood donations;

Approving or designating laboratories authorized to perform such testing;

Establishing labeling and recordkeeping requirements; and

Creating procedures for enforcement and compliance.

Section 2. This act shall take effect July 1, 2026.

Talking Points: Patients’ Right to Know About mRNA in Blood Transfusions

Transparency is a basic patient right. Patients receiving a blood transfusion should have full disclosure about what is in the blood they are receiving – including whether it contains evidence of synthetic mRNA by presence of only the spike protein antibody.

Informed consent is the cornerstone of medical ethics. No patient should unknowingly receive a blood product with components they might object to for personal, medical, or religious reasons.

This is not about banning blood donations. It is about choice. Patients have the right to make decisions about their own health care and medical treatments.

Testing for mRNA produced spike protein protects both patients and providers. Clear labeling and disclosure reduce liability for hospitals, physicians, and blood banks, while building trust with patients.

We already test blood for dozens of conditions. Adding mRNA produced spike protein screening is simply another safeguard – consistent with existing protocols to ensure safe and transparent transfusions.

Trust in the blood supply must be preserved. When patients know their rights are being respected, confidence in blood donation and transfusion systems grows stronger.

Florida can lead the nation. By requiring transparency and testing, Florida ensures its citizens are protected, informed, and respected in one of the most critical areas of health care – life-saving blood transfusions.